HLA Polymorphisms Predict NY-ESO-1 Tumor Antigen Serology and Overall Survival in Epithelial Ovarian Cancer

被引：0
|
作者：
Daudi, Sayeema [1 ]
Brady, Mark [1 ]
Miliotto, Tony [1 ]
Matsuzaki, Junko [1 ]
Lele, Shashikant [1 ]
Odunsi, Kunle [1 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
来源：
REPRODUCTIVE SCIENCES | 2013年 / 20卷 / S3期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：86A / 86A
页数：1
相关论文
共 50 条
  • [41] Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1, by distinct human dendritic cell populations
    Nagata, Y
    Ono, S
    Matsuo, M
    Gnjatic, S
    Valmori, D
    Ritter, G
    Garrett, W
    Old, LJ
    Mellman, I
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (16) : 10629 - 10634
  • [42] Directed evolution for improved secretion of cancer-testis antigen NY-ESO-1 from yeast
    Piatesi, Andrea
    Howland, Shanshan W.
    Rakestraw, James A.
    Renner, Christoph
    Robson, Neil
    Cebon, Jonathan
    Maraskovsky, Eugene
    Ritter, Gerd
    Old, Lloyd
    Wittrup, K. Dane
    PROTEIN EXPRESSION AND PURIFICATION, 2006, 48 (02) : 232 - 242
  • [43] Antigen-specific immunity in neuroblastoma patients: Antibody and T-cell recognition of NY-ESO-1 tumor antigen
    Rodolfo, M
    Luksch, R
    Stockert, E
    Chen, YT
    Collini, P
    Ranzani, T
    Lombardo, C
    Dalerba, P
    Rivoltini, L
    Arienti, F
    Fossati-Bellani, F
    Old, LJ
    Parmiani, G
    Castelli, C
    CANCER RESEARCH, 2003, 63 (20) : 6948 - 6955
  • [44] Dendritic cells can directly acquire the NY-ESO-1 tumor antigen and cross-present to CTL
    Zeng, G
    Robbins, PF
    Rosenberg, SA
    FASEB JOURNAL, 2002, 16 (05): : A1232 - A1232
  • [45] CD4+ T Effectors Specific for the Tumor Antigen NY-ESO-1 Are Highly Enriched at Ovarian Cancer Sites and Coexist with, but Are Distinct from, Tumor-Associated Treg
    Ayyoub, Maha
    Pignon, Pascale
    Classe, Jean-Marc
    Odunsi, Kunle
    Valmori, Danila
    CANCER IMMUNOLOGY RESEARCH, 2013, 1 (05) : 303 - 308
  • [46] Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer
    Odunsi, Kunle
    Qian, Feng
    Matsuzaki, Junko
    Mhawech-Fauceglia, Paulette
    Andrews, Christopher
    Hoffman, Eric W.
    Pan, Linda
    Ritter, Gerd
    Villella, Jeannine
    Thomas, Bridget
    Rodabaugh, Kerry
    Lele, Shashikant
    Shrikant, Protul
    Old, Lloyd J.
    Gnjatic, Sacha
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (31) : 12837 - 12842
  • [47] Identification of B cell epitopes recognized by antibodies specific for the tumor antigen NY-ESO-1 in cancer patients with spontaneous immune responses
    Valmori, D
    Souleimanian, NE
    Hesdorffer, CS
    Ritter, G
    Old, LJ
    Ayyoub, M
    CLINICAL IMMUNOLOGY, 2005, 117 (01) : 24 - 30
  • [48] Immunization of HLA-A*0201 and/or HLA-DPβ1*04 patients with metastatic melanoma using epitopes from the NY-ESO-1 antigen
    Khong, HT
    Yang, JC
    Topalian, SL
    Sherry, RM
    Mavroukakis, SA
    White, DE
    Rosenberg, SA
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : 472 - 477
  • [49] Prognostic significance of MAGE-A10 and NY-ESO-1 cancer-testis antigen in breast cancer.
    Crnjevic, Tanja Badovinac
    Razumovic, Jasminka Jakic
    Spagnoli, Giulio C.
    Podolski, Paula
    Saric, Nera
    Koretic, Martina Basic
    Juretic, Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [50] Serum NY-ESO-1 and p53 antibodies as useful tumor markers in gastric cancer
    Kawada, Junji
    Saito, Takuro
    Kurokawa, Yukinori
    Kawabata, Ryohei
    Takeno, Atsushi
    Takeoka, Tomohira
    Nose, Yohei
    Wada, Hisashi
    Eguchi, Hidetoshi
    Doki, Yuichiro
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2024, 8 (02): : 243 - 250
12345